Research Article
Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma
Table 4
Multivariate analysis to identify independent risk factors of progression-free survival and overall survival in CTC-positive HCC patients.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bold values indicate statistical significance. AFP: alpha-fetoprotein; CTC: circulating tumor cells; HBsAg: hepatitis B surface antigen; HCC: hepatocellular carcinoma; MVI: microvascular invasions; PVT: portal vein thrombosis; RFA: radiofrequency ablation; UCSF: University of California San Francisco. |